Ticker
YMABCompany Name
Y-MABS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 117.21M | $ 69.58M | 59.36% |
3/31/2025 | $ 112.61M | $ 72.55M | 64.43% |
12/31/2024 | $ 119.9M | $ 72.43M | 60.41% |
9/30/2024 | $ 120.92M | $ 75.11M | 62.11% |
6/30/2024 | $ 144.03M | $ 76.7M | 53.25% |
3/31/2024 | $ 123.31M | $ 73.02M | 59.21% |
12/31/2023 | $ 127.87M | $ 73.4M | 57.4% |
9/30/2023 | $ 128.88M | $ 81.51M | 63.24% |
6/30/2023 | $ 132.4M | $ 73.76M | 55.71% |
3/31/2023 | $ 137.44M | $ 67.21M | 48.9% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for Y-MABS THERAPEUTICS INC is calculated as follows: GP [ $ 0 ] / Assets [ $ 143.19M ]
(=) GPA [ 0% ]
Minimum
Sep 30, 2020
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 4.13K |
---|---|
min | -50.32% |
max | 83.98% |
average | 20.16% |
median | 15.35% |
std | 19.95% |